Showing Results for
From:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 34) Peer-ReviewedTout au long de l'histoire de la medecine, les progres technologiques ont permis aux medecins de comprendre et de diagnostiquer des syndromes qui autrefois demeuraient des enigmes. Bien qu'Hippocrate decrivait deja...
From:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 14) Peer-ReviewedThroughout the history of medicine, technological progress has enabled physicians to understand and diagnose previously enigmatic syndromes. Although Hippocrates described many of the features of tuberculosis, it was not...
From:CMAJ: Canadian Medical Association Journal (Vol. 193, Issue 27) Peer-Reviewed1 Le tocilizumab est un medicament immunomodulateur qui bloque l'activite de l'interleukine-6 (IL-6) De nombreux patients atteints de la forme grave de la maladie a coronavirus 2019 (COVID-19) presentent des rates...
From:CMAJ: Canadian Medical Association Journal (Vol. 193, Issue 15) Peer-Reviewed1 Tocilizumab is an immunomodulatory drug that blocks the activity of interleukin-6 (IL-6) Many patients with severe coronavirus disease 2019 (COVID-19) have immune misfiring characterized by a defective interferon...
From:Clinical Chemistry (Vol. 64, Issue 4) Peer-ReviewedCitation Only
From:Clinical Chemistry (Vol. 67, Issue 2) Peer-ReviewedCitation Only
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it